Yakun Wang

机构：Capital Medical University, Fudan University, XinHua Hospital, Zhongshan Hospital · ORCID：0000-0003-0568-8783

发表论文 58 篇 · 总被引 748 次 · h-index 13

代表论文

• Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data (2024 · Signal Transduction and Targeted Therapy · 被引 102)
• PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 13)
• Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study (2023 · Renal Failure · 被引 12)
• A retrospective study of baseline peritoneal transport character and left ventricular hypertrophy in incident peritoneal dialysis patients: interrelationship and prognostic impacts (2022 · Renal Failure · 被引 9)
• A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy (2024 · Renal Failure · 被引 8)
• The value of serum TRAP1 in diagnosing small cell lung cancer and tumor immunity (2023 · Experimental Biology and Medicine · 被引 8)